Detalles de la búsqueda
1.
Asthma control in the United States: relationships between short-acting ß2-agonist and systemic corticosteroid use.
Ann Allergy Asthma Immunol
; 2024 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38740134
2.
Assessing meaningful change in the Asthma Impairment and Risk Questionnaire.
Ann Allergy Asthma Immunol
; 2024 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38369256
3.
Patterns of rescue and maintenance therapy claims surrounding a clinical encounter for an asthma exacerbation.
Ann Allergy Asthma Immunol
; 131(4): 458-465.e1, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37343824
4.
The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma control.
Ann Allergy Asthma Immunol
; 131(4): 436-443.e1, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37105501
5.
Evaluating construct validity of the Asthma Impairment and Risk Questionnaire using a 3-month exacerbation recall.
Ann Allergy Asthma Immunol
; 128(5): 544-552.e3, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35123077
6.
Validation of the Onset of Effect Questionnaire in Participants With Chronic Obstructive Pulmonary Disease.
Chronic Obstr Pulm Dis
; 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38722709
7.
Impact of Clinical Characteristics and Biomarkers on AIRQ Exacerbation Prediction Ability.
J Allergy Clin Immunol Pract
; 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38705273
8.
Relationship Between Asthma Control as Measured by the Asthma Impairment and Risk Questionnaire (AIRQ) and Patient Perception of Disease Status, Health-Related Quality of Life, and Treatment Adherence.
J Asthma Allergy
; 16: 59-72, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36636702
9.
The Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma Exacerbations.
J Allergy Clin Immunol Pract
; 10(12): 3204-3212.e2, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35998877
10.
Demographics, Treatment Patterns, and Morbidity in Patients with Exercise-Induced Bronchoconstriction: An Administrative Claims Data Analysis.
J Asthma Allergy
; 14: 1485-1495, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34924763
11.
Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies.
Int J Chron Obstruct Pulmon Dis
; 15: 2889-2900, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33204085
12.
Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure.
J Allergy Clin Immunol Pract
; 8(7): 2263-2274.e5, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32387166
13.
Confirmatory cross-sectional validation of the Asthma Impairment and Risk Questionnaire.
J Allergy Clin Immunol Pract
; 11(11): 3531-3533.e1, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37474101
Resultados
1 -
13
de 13
1
Próxima >
>>